Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting - Publikation - Autoren - KSSG Forschungsdatenbank

Publikation

Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting

Wissenschaftlicher Artikel/Review - 21.03.2009

Brändle Michael, Goodall G, Erny-Albrecht K M, Erdmann E, Valentine W J

Brändle, Michael

Chefarzt
Allgemeine Innere Medizin | Hausarztmedizin und Notfallmedizin, Endokrinologie | Diabetologie | Osteologie | Stoffwechselerkrankungen · Dept. I

Goodall, G

Erny-Albrecht, K M

Erdmann, E

Valentine, W J